Peptide-pulsed MHC class II semi-allogeneic dendritic cell vaccine induces more efficacious anti-tumor responses
Technology
E-103-2023
Patent ID
E-103-2023-0-US-01
Country
US
Application Type
Patent Status
Expired
Patent Number
Publication Number
Application Number
63/456,176
IC
NCI
Date Filed
Date Issued
Patent PDF